Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Loc Phuoc Thai, Agnes Isabelle Vitry & John Robert Moss. (2018) Price and utilisation differences for statins between four countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 71-81.
Read now
Read now
L. P. Thai, J. R. Moss, B. Godman & A. I. Vitry. (2016) Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme. Expert Review of Pharmacoeconomics & Outcomes Research 16:3, pages 419-433.
Read now
Read now
Miao Hu & Brian Tomlinson. (2014) Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 51-65.
Read now
Read now
Rajesh K Aggarwal & Refai Showkathali. (2013)
Rosuvastatin calcium in acute coronary syndromes. Expert Opinion on Pharmacotherapy 14:9, pages 1215-1227.
Read now
Read now
Rahul Yadav, Michael France, Naveed Younis, Salam Hama, Basil J Ammori, See Kwok & Handrean Soran. (2012) Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opinion on Pharmacotherapy 13:9, pages 1345-1362.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2009) Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. Expert Review of Cardiovascular Therapy 7:11, pages 1317-1327.
Read now
Read now
Articles from other publishers (24)
Deepak Bhatnagar, Jonathan Schofield & Handrean Soran. 2020. Clinical Molecular Medicine. Clinical Molecular Medicine
245
265
.
Abhaysingh Bhadoriya, Mallika Sanyal, Priyanka A. Shah & Pranav S. Shrivastav. (2018) Simultaneous quantitation of rosuvastatin and ezetimibe in human plasma by LC-MS/MS: Pharmacokinetic study of fixed-dose formulation and separate tablets. Biomedical Chromatography 32:10, pages e4291.
Crossref
Crossref
CJ Poston, TC Pierce, Y Li, CW Brinson, Z Lu, AW Lauer, RS Leite & Y Huang. (2016) Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis. Oral Diseases 22:5, pages 438-444.
Crossref
Crossref
MARIOLA HERBET, MONIKA GAWROŃSKA-GRZYWACZ, MAGDALENA IZDEBSKA, IWONA PIĄTKOWSKA-CHMIEL & EWA JAGIEŁŁO-WÓJTOWICZ. (2016) Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in rats. Experimental and Therapeutic Medicine 11:4, pages 1459-1464.
Crossref
Crossref
Damjan Šterk, Werner Zaugg, Ulrich Beutler, Eric M. Loeser, Kapa Prasad & Zdenko Časar. (2016) Efficient and highly stereoselective assembly of rosuvastatin. Tetrahedron Letters 57:12, pages 1338-1341.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
285
315
.
P Escudero, A Navarro, C Ferrando, E Furio, H Gonzalez-Navarro, M Juez, M J Sanz & L Piqueras. (2015)
Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE
−/−
mice and angiogenesis
. British Journal of Pharmacology 172:12, pages 2946-2960.
Crossref
Crossref
Gokhan Kurt, Emre C. Gokce, Berker Cemil, Zuhal Yildirim, Gulnur T. Kaplanoglu, Emre Durdag & Bulent Erdogan. (2015) Neuroprotective Effects of Rosuvastatin in Spinal Cord Ischemia-Reperfusion Injury in Rabbits. Neurosurgery Quarterly 25:2, pages 189-196.
Crossref
Crossref
Jian Li, Hongni Wang, Li Liu & Jiangtao Sun. (2014) Metal-free, visible-light photoredox catalysis: transformation of arylmethyl bromides to alcohols and aldehydes. RSC Adv. 4:91, pages 49974-49978.
Crossref
Crossref
Damjan Šterk, Marko Jukič & Zdenko Časar. (2013) Application of Flow Photochemical Bromination in the Synthesis of a 5-Bromomethylpyrimidine Precursor of Rosuvastatin: Improvement of Productivity and Product Purity. Organic Process Research & Development 17:1, pages 145-151.
Crossref
Crossref
J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker & E.M. Wain. (2013) U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma. British Journal of Dermatology 168:1, pages 192-200.
Crossref
Crossref
Jonathan Wagner & J. Steven Leeder. (2012) Pediatric Pharmacogenomics. Pediatric Clinics of North America 59:5, pages 1017-1037.
Crossref
Crossref
R AraA PandorJ StevensR RafiaSE WardA ReesPN DurringtonTM ReynoldsAS WierzbickiM Stevenson. (2011) Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?. European Journal of Preventive Cardiology 19:3, pages 474-483.
Crossref
Crossref
Damjan Šterk, Zdenko Časar, Marko Jukič & Janez Košmrlj. (2012) Concise and highly efficient approach to three key pyrimidine precursors for rosuvastatin synthesis. Tetrahedron 68:9, pages 2155-2160.
Crossref
Crossref
Ahai LuvaiWycliffe MbagayaAlistair S. HallJulian H. Barth. (2012) Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease. Clinical Medicine Insights: Cardiology 6, pages CMC.S4324.
Crossref
Crossref
Kosmas I. Paraskevas, Ioannis Kotsikoris, Sotirios A. Koupidis, Alexandros A. Tzovaras & Dimitri P. Mikhailidis. (2010) Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. International Urology and Nephrology 42:4, pages 999-1006.
Crossref
Crossref
Venkata M. Alla, Manu Kaushik & Aryan Mooss. (2010) Targeting Residual Risk: The Rationale for the Use of Non-HDL Cholesterol. Southern Medical Journal 103:5, pages 434-439.
Crossref
Crossref
Kosmas I. Paraskevas, Eleftherios Anastasakis, Maria Andrikopoulou & Dimitri P. Mikhailidis. (2009) Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure?. Angiology 61:1, pages 5-7.
Crossref
Crossref
Rina P. M. Wong & Timothy M. E. Davis. (2009) Statins as Potential Antimalarial Drugs: Low Relative Potency and Lack of Synergy with Conventional Antimalarial Drugs. Antimicrobial Agents and Chemotherapy 53:5, pages 2212-2214.
Crossref
Crossref
Gianna Fabbri & Aldo Pietro Maggioni. (2009) Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?. Advances in Therapy 26:5, pages 469-487.
Crossref
Crossref
Sonja V. Sorensen, Kevin D. Frick, Alexander Wade, Robert Simko & Russel Burge. (2009) Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Clinical Therapeutics 31:4, pages 862-879.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:1.
Crossref
Crossref
Severo de Paoli, Adenilson de Souza da Fonseca, Flávia de Paoli, Mauro Geller, Giuseppe Antonio Presta, Sebastião David Santos-Filho & Mário Bernardo-Filho. (2008) A Review of Scientific Papers About Head and Neck Cancers. Brazilian Archives of Biology and Technology 51:spe, pages 63-69.
Crossref
Crossref
Sebastião David Santos-Filho, Giuseppe Antonio Presta, Severo de Paoli, Sotiris Missailids, Adenilson de Souza da Fonseca & Mario Bernardo-Filho. (2008) Radiotherapy, cancer and some anatomical structures related with the pelvic floor: an evaluation of the scientific literature. Brazilian Archives of Biology and Technology 51:spe, pages 45-50.
Crossref
Crossref